Clinical Trials Browser

Interventional × Non Small Cell Lung Cancer Metastatic × Thoracic × Clear all

NCT06741085 2026-04-13

A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain

Phase 2 Recruiting

Non Small Cell Lung Cancer Metastatic

NCT05853887 2026-03-11

iNUDGE

Phase NA Active not recruiting

Non Small Cell Lung Cancer Metastatic

NCT07462728 2026-03-10

Phase III, Multicenter, Randomized Controlled Clinical Study of Three-Dimensional Radiotherapy for Primary Tumors in Non-Oligometastatic Stage IV Non-Small Cell Lung Cancer

Phase NA Not yet recruiting

Non Small Cell Lung Cancer Metastatic

NCT03133546 2026-02-06

BOOSTER

Phase 2 Completed

155 enrolled 23 charts

Non Small Cell Lung Cancer Metastatic

NCT03977194 2025-11-18

ELDERLY

Phase 3 Active not recruiting

Non Small Cell Lung Cancer Metastatic

NCT05117242 2025-11-06

Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer

Phase 2 Active not recruiting

Non Small Cell Lung Cancer Metastatic

NCT04621188 2025-09-24

Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)

Phase 2 Active not recruiting

Non Small Cell Lung Cancer Metastatic

NCT04111705 2025-04-01

ORAKLE

Phase 2 Completed

Non Small Cell Lung Cancer Metastatic

NCT04951583 2024-08-07

FMT-LUMINATE

Phase 2 Active not recruiting

DermatologicThoracic

Non Small Cell Lung Cancer Metastatic

NCT05668650 2024-07-16

Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC

Phase 3 Recruiting

Non Small Cell Lung Cancer Metastatic

NCT06378892 2024-04-23

ALK-PPL

Phase 2 Recruiting

Non Small Cell Lung Cancer Metastatic

NCT03168464 2023-04-24

Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)

Phase 1/2 Terminated

15 enrolled 9 charts

Non Small Cell Lung Cancer Metastatic

NCT03732482 2019-01-29

Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases

Phase 2/3 Unknown

Non Small Cell Lung Cancer Metastatic